Search Results

What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease?…

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research- 2025-04-02

Multidisciplinary research on neurodegenerative diseases Multidisciplinary research on neurodegenerative diseases and related brain disorders with the aim to better understand, treat, and cure. A strategic research area with pioneering…

https://www.multipark.lu.se/about-multipark- 2025-10-23

Donna Wilcock, Indiana University School of Medicine, USAThomas Perlmann, Karolinska Institutet, StockholmMarina Romero-Ramos, Aarhus University, DenmarkBart De Strooper, KU Leuven, Belgium, and University College London, EnglandGünther…

https://www.multipark.lu.se/frontiers-neuroscience-seminar-series/previous-frontiers-neuroscience-talks- 2025-03-28

How MultiPark research creates value for society Our research is of high societal relevance. Living with a progressive neurodegenerative disease has detrimental effects for the individual and next of kins, including inducing major societal…

https://www.multipark.lu.se/societal-impact- 2025-11-17

Evidence-based clinical guidelinesOur senior researchers contribute to the development of national and international evidence-based (GRADE) clinical guidelines since 2014, advancing standards of care across the field. Below are some…

https://www.multipark.lu.se/clinical-guidelines- 2025-04-28

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from…

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain- 2025-04-14

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the…

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method- 2025-04-15

PROGRAM FOR 202524 April, 16:00, Segerfalk lecture hall, BMC A10Professor Bill Seeley, UCSF Memory and Aging Center, USALecture title: "Upstream pathogenesis in FTD/ALS"Lecture host: Alexander Santillo Bio-sketch:Professor Seeley is a…

https://www.multipark.lu.se/frontiers-neuroscience-seminar-series- 2025-03-28

MultiPark researchers contribute to international recommendations regarding diagnostics, prognostics, and treatments of neurodegenerative disorders. Below are some examples. 2025The Alzheimer's Association Global Biomarker Standardization…

https://www.multipark.lu.se/international-recommendations- 2025-04-28

Meet our scientist Gesine Paul-Visse to learn what happens at the interface where the brain and the body meet: the blood-brain barrier. Here, a very specialized cell, the pericyte, protects the brain and responds strongly to disease…

https://www.multipark.lu.se/article/meet-our-scientists-podcast-gesine-paul-visse-about-brains-frontline- 2025-05-22

Researchers at MultiPark have uncovered in mice how the protein TDP-43, known for its role in several neurodegenerative diseases, disrupts the hypothalamus, the brain’s key center for metabolic control. Their study sheds new light on the…

https://www.multipark.lu.se/article/protein-mismanagement-brains-control-center-fuels-early-symptoms-neurodegenerative-diseases- 2025-06-04

An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could explain why some patients develop impulsive and compulsive behaviors as a…

https://www.multipark.lu.se/article/brain-activation-pattern-behind-impulsivity-parkinsons-treatment-discovered- 2025-06-26

Travel GrantsMultiPark has a call to apply for travel grants. Eligible to apply for the grants are those from PhD student level and up to, but not including, the position of group leader and/or docent. Applications must be submitted at…

https://www.multipark.lu.se/funding-opportunities- 2025-03-21

Are you involved in innovative research that may lead to the development of novel diagnostics or therapeutics or that may pave the way for new research tools, technologies or methodologies? You now have the possibility to get support, up…

https://www.multipark.lu.se/innovation/innovation-support- 2025-03-17

Meet our scientist, Dr. Niklas Mattsson-Carlgren! He explains why studying biomarkers is essential to advancing Alzheimer’s research. Niklas Mattsson-Carlgren is part of the Clinical Memory Research group, a leading centre in the…

https://www.multipark.lu.se/article/meet-our-scientists-podcast-niklas-mattsson-carlgren-about-biomarkers-and-future-alzheimers- 2025-08-01

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the…

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care- 2025-09-01

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays…

https://www.multipark.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease- 2025-08-29

Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With the TAU-TIME project, Jacob Vogel aims to advance knowledge…

https://www.multipark.lu.se/article/time-unite-lab-and-clinic-15-million-eu-build-ai-model-alzheimers-disease- 2025-09-04

15 May 2026 15:00 to 16:00 | Lecture/talk Welcome to a Frontiers in Neuroscience talk by Juho Joutsa, MD, PhD Professor of neurology, University of Turku, Finland. Lecture title: Post-stroke movement disordersLecture host: Per Odin About…

https://www.multipark.lu.se/calendar/frontiers-neuroscience-seminar-post-stroke-movement-disorders- 2025-12-04

Early diagnosis is key to receiving proper care and advancing research on future therapies for neurodegenerative diseases such as Parkinson’s and dementia with Lewy bodies. New research from Skåne University Hospital and Lund University…

https://www.multipark.lu.se/article/smell-test-cuts-need-invasive-parkinsons-screening- 2025-09-19